Human Genome Sciences Stock
Equities
US4449031081
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2012 | Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources | RE |
2012 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
1st Jan change | Capi. | |
---|---|---|
+0.64% | 43.84B | |
+4.96% | 41.68B | |
+45.38% | 41.25B | |
-11.96% | 27.04B | |
+6.02% | 25.53B | |
-25.43% | 18.18B | |
-3.98% | 12.29B | |
+25.19% | 12.29B | |
+7.06% | 11.15B |
- Stock Market
- Equities
- Stock